Cite
Apatinib as Salvage Treatment in BRCA2-Mutated Advanced Lung Adenocarcinoma.
MLA
Zeng, Da-Xiong, et al. “Apatinib as Salvage Treatment in BRCA2-Mutated Advanced Lung Adenocarcinoma.” American Journal of Therapeutics, vol. 26, no. 6, Nov. 2019, pp. e747–48. EBSCOhost, https://doi.org/10.1097/MJT.0000000000000905.
APA
Zeng, D.-X., Huang, J.-A., & Jiang, J.-H. (2019). Apatinib as Salvage Treatment in BRCA2-Mutated Advanced Lung Adenocarcinoma. American Journal of Therapeutics, 26(6), e747–e748. https://doi.org/10.1097/MJT.0000000000000905
Chicago
Zeng, Da-Xiong, Jian-An Huang, and Jun-Hong Jiang. 2019. “Apatinib as Salvage Treatment in BRCA2-Mutated Advanced Lung Adenocarcinoma.” American Journal of Therapeutics 26 (6): e747–48. doi:10.1097/MJT.0000000000000905.